1-16 of 16
Christel Weiss
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASXL1 Mutations Are Associated with a Response to the Combination of Alvocidib and 5-Azacytidine in Higher-Risk Myelodysplastic Syndromes

Vladimir Riabov, Qingyu Xu, Nanni Schmitt, Alexander Streuer, Guo Ge, Johann-Christoph Jann, Alina Wein, Eva Altrock, Felicitas Rapp, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Melda Göl, Mark Wunderlich, Ahmed Jawhar, Ali Darwich, Patrick Wuchter, Christel Weiss, Jason M Foulks, Daniel T. Starczynowski, Feng-Chun Yang, Georgia Metzgeroth, Laurenz Steiner, Wolf-Karsten Hofmann, Daniel Nowak, Mohamad Jawhar
Journal: Blood
Blood (2022) 140 (Supplement 1): 9749–9750.
https://doi.org/10.1182/blood-2022-165298
Published: 2022
Journal Articles

Preclinical Assessment of Alvocidib in Combination with 5-Azacytidine in High-Risk Myelodysplastic Syndromes

Vladimir Riabov, Qingyu Xu, Nanni Schmitt, Alexander Streuer, Johann-Christoph Jann, Alina Wein, Eva Altrock, Arwin Mehralivand, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Mohamad Jawhar, Christel Weiss, Georgia Metzgeroth, Jason M Foulks, Wolf-Karsten Hofmann, Daniel Nowak
Journal: Blood
Blood (2021) 138 (Supplement 1): 4649.
https://doi.org/10.1182/blood-2021-150778
Published: 2021
Journal Articles

Accumulation of DNA Damage and Alteration of the DNA Damage Response in Chronic Myeloid Leukemia

Henning D. Popp, Vanessa Kohl, MSc, Johanna Flach, PhD, Susanne Brendel, MTA, Helga Kleiner, MTA, Wolfgang Seifarth, PhD, Christel Weiss, PhD, Susanne Saussele, MD, Wolf-Karsten Hofmann, MD PhD, Alice Fabarius, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5364.
https://doi.org/10.1182/blood-2019-122698
Published: 2019
Journal Articles

Anti-Leukemic Efficacy of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies

Vanessa Kohl, MSc, Susanne Brendel, MTA, Johanna Flach, PhD, Helga Kleiner, MTA, Christel Weiss, PhD, Wolfgang Seifarth, PhD, Daniel Nowak, MD, Wolf-Karsten Hofmann, MD PhD, Alice Fabarius, PhD, Henning D. Popp
Journal: Blood
Blood (2019) 134 (Supplement_1): 5056.
https://doi.org/10.1182/blood-2019-122672
Published: 2019
Journal Articles

Genomic CDKN2A/2B deletions in adult Ph + ALL are adverse despite allogeneic stem cell transplantation

Heike Pfeifer, Katharina Raum, Sandra Markovic, Verena Nowak, Stephanie Fey, Julia Obländer, Jovita Pressler, Verena Böhm, Monika Brüggemann, Lydia Wunderle, Andreas Hüttmann, Ralph Wäsch, Joachim Beck, Matthias Stelljes, Andreas Viardot, Fabian Lang, Dieter Hoelzer, Wolf-Karsten Hofmann, Hubert Serve, Christel Weiss, Nicola Goekbuget, Oliver G. Ottmann, Daniel Nowak
Journal: Blood
Blood (2018) 131 (13): 1464–1475.
https://doi.org/10.1182/blood-2017-07-796862
Published: 2018
Includes: Supplemental data
Journal Articles

Increase of DNA Damage and Alteration of the DNA Damage Response in Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia

Henning D. Popp, MD, Susanne Brendel, MTA, Sabrina Ruppenthal, PhD, Helga Kleiner, MTA, Sven Schneider, MD, Torsten Schulze, MD, Christel Weiss, PhD, Frederik Wenz, MD, Wolf-Karsten Hofmann, MD, Alice Fabarius
Journal: Blood
Blood (2017) 130 (Supplement 1): 4300.
https://doi.org/10.1182/blood.V130.Suppl_1.4300.4300
Published: 2017
Journal Articles

An Optimized Risk Stratification Model in Acute Promyelocytic Leukemia Identifies Patients with an Exceptionally Good Prognosis Regarding the Incidence of Relapse

Anna Hecht, MD, Daniel Nowak, Verena Nowak, Benjamin Hanfstein, MD, Thomas Büchner, MD, Karsten Spiekermann, MD, Christel Weiss, Wolf-Karsten Hofmann, Eva Lengfelder, MD, Florian Nolte
Journal: Blood
Blood (2014) 124 (21): 72.
https://doi.org/10.1182/blood.V124.21.72.72
Published: 2014
Journal Articles

Cluster Analysis Followed by Network Meta-Analysis to Compare Efficacy and Safety of Dabigatran, Rivaroxaban and Apixaban After Elective Total Knee and Hip Replacement Surgery

Job Harenberg, Prof., Dr., Svetlana Marx, Shabnam Zolfaghari, Christel Weiss, Dr., Martin Wehling, Prof., Dr., Astrid Schulze, Dr., Ola E Dahl, MD
Journal: Blood
Blood (2012) 120 (21): 3409.
https://doi.org/10.1182/blood.V120.21.3409.3409
Published: 2012
Journal Articles

Which Patients Would Be Willing to Change Anticoagulation From Vitamin-K Antagonists to a New Oral Anticoagulant?

Job Harenberg, Svetlana Marx, Nadja Abou-Ayash, Christophe Kremer, Vera Hoeing, Katrin Schirk, Christel Weiss, Lutz Froelich
Journal: Blood
Blood (2011) 118 (21): 4318.
https://doi.org/10.1182/blood.V118.21.4318.4318
Published: 2011
Journal Articles

Identification of Recurrent Submicroscopic Deletions of chromosome1q31.3 As Possible Molecular Prognostic Markers in Acute Promyelocytic Leukemia (APL)

Daniel Nowak, MD, Marion Klaumuenzer, Benjamin Hanfstein, MD, Maximilian Mossner, Florian Nolte, MD, Verena Nowak, Julia Oblaender, Anna Hecht, Gero Hütter, MD, Seishi Ogawa, MD, PhD, Alexander Kohlmann, PhD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD, Jan Braess, MD, Wolfgang Seifarth, PhD, Alice Fabarius, PhD, Philipp Erben, MD, Susanne Saussele, MD, Martin C. Müller, MD, Thomas Buechner, MD, PhD, Christel Weiss, Dr., Wolf-Karsten Hofmann, Eva Lengfelder, MD
Journal: Blood
Blood (2011) 118 (21): 420.
https://doi.org/10.1182/blood.V118.21.420.420
Published: 2011
Journal Articles

Relation of Personality Traits in Patients with Oral Anticoagulant Therapy to Attitudes towards Treatment with Vitamin-K Antagonists.

Job Harenberg, Lutz Frölich, Marie-Theres Felten, Christel Weiss
Journal: Blood
Blood (2009) 114 (22): 4183.
https://doi.org/10.1182/blood.V114.22.4183.4183
Published: 2009
Journal Articles

Stability of the INR in Relation to Personality Traits in Patients On Stable Oral Anticoagulant Therapy.

Job Harenberg, Christel Weiss, Marie-Theres Felten, Lutz Frölich
Journal: Blood
Blood (2009) 114 (22): 4178.
https://doi.org/10.1182/blood.V114.22.4178.4178
Published: 2009
Journal Articles

Influence of Genetic Polymorphisms of VKORC1 and CYP2C9 in Patients on Phenprocoumon Steady-State Dose Requirements

Weidong Wu, Job Harenberg, Christel Weiss, Julia Kirchheiner, Simone Stehle, Uwe Fuhr, Christoph Gleiter
Journal: Blood
Blood (2008) 112 (11): 4051.
https://doi.org/10.1182/blood.V112.11.4051.4051
Published: 2008
Journal Articles

Anticoagulant Effects of the Low-Molecular-Weight Heparin Certoparin in Combination with Phenprocoumon in Patients with Recent Atrial Fibrillation Undergoing Cardioversion

Job Harenberg, Jolanta Wierdack, Christel Weiss, Christina Giese, Claudia Abletshauser, Ulrich Tebbe
Journal: Blood
Blood (2008) 112 (11): 4057.
https://doi.org/10.1182/blood.V112.11.4057.4057
Published: 2008
Journal Articles

Pharmacodynamic Analysis of the Anticoagulant Effects of Idraparinuxparinux after Termination of 6 and 12 Months Therapy for Prevention of Recurrent Venous Thromboembolism: Observations after the vanGogh Trials.

Job Harenberg, MD, Ingrid Joerg, Antje Hagedorn, Christina Giese, Christel Weiss, Gerd Mikus
Journal: Blood
Blood (2007) 110 (11): 1883.
https://doi.org/10.1182/blood.V110.11.1883.1883
Published: 2007
Journal Articles

Long Acting Anticoagulant Effects of Idraparinux in Patients Treated for Prophylaxis of Recurrent Venous Thromboembolism.

Job Harenberg, Ingrid Joerg, M.D., Christel Weiss, M.D., Tivadar Fenyvesi, M.D.
Journal: Blood
Blood (2006) 108 (11): 899.
https://doi.org/10.1182/blood.V108.11.899.899
Published: 2006